Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 16 studies | 27% ± 10% | |
microglial cell | 9 studies | 26% ± 8% | |
oligodendrocyte | 9 studies | 29% ± 9% | |
adipocyte | 8 studies | 26% ± 6% | |
astrocyte | 8 studies | 30% ± 12% | |
glutamatergic neuron | 6 studies | 46% ± 23% | |
interneuron | 6 studies | 35% ± 22% | |
macrophage | 6 studies | 28% ± 8% | |
oligodendrocyte precursor cell | 6 studies | 28% ± 10% | |
GABAergic neuron | 6 studies | 41% ± 19% | |
smooth muscle cell | 6 studies | 20% ± 4% | |
ciliated cell | 5 studies | 22% ± 5% | |
fibroblast | 5 studies | 26% ± 7% | |
epithelial cell | 4 studies | 33% ± 13% | |
dendritic cell | 4 studies | 19% ± 4% | |
endothelial cell of lymphatic vessel | 4 studies | 25% ± 7% | |
pericyte | 4 studies | 24% ± 9% | |
basal cell | 4 studies | 27% ± 17% | |
hematopoietic precursor cell | 3 studies | 17% ± 2% | |
GABAergic interneuron | 3 studies | 19% ± 5% | |
neuron | 3 studies | 31% ± 13% | |
cardiac muscle cell | 3 studies | 18% ± 2% | |
retinal rod cell | 3 studies | 22% ± 6% | |
hepatocyte | 3 studies | 35% ± 16% | |
ependymal cell | 3 studies | 27% ± 11% | |
alveolar macrophage | 3 studies | 21% ± 5% | |
monocyte | 3 studies | 21% ± 3% | |
type II pneumocyte | 3 studies | 19% ± 4% | |
lymphocyte | 3 studies | 31% ± 9% | |
goblet cell | 3 studies | 30% ± 17% | |
transit amplifying cell | 3 studies | 31% ± 21% | |
mucus secreting cell | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3169.66 | 1445 / 1445 | 100% | 19.88 | 183 / 183 |
intestine | 100% | 3442.17 | 966 / 966 | 100% | 14.82 | 525 / 527 |
stomach | 100% | 2593.92 | 359 / 359 | 99% | 16.30 | 284 / 286 |
lung | 100% | 3149.54 | 578 / 578 | 99% | 15.12 | 1145 / 1155 |
breast | 100% | 4042.04 | 459 / 459 | 99% | 21.06 | 1106 / 1118 |
pancreas | 100% | 2126.60 | 327 / 328 | 99% | 12.93 | 176 / 178 |
thymus | 100% | 4034.67 | 653 / 653 | 99% | 17.23 | 596 / 605 |
brain | 99% | 2051.48 | 2623 / 2642 | 99% | 16.33 | 699 / 705 |
bladder | 100% | 3632.95 | 21 / 21 | 98% | 13.33 | 494 / 504 |
uterus | 100% | 4688.34 | 170 / 170 | 98% | 15.01 | 448 / 459 |
prostate | 100% | 2950.78 | 245 / 245 | 97% | 13.88 | 488 / 502 |
skin | 100% | 4139.25 | 1809 / 1809 | 96% | 14.85 | 452 / 472 |
adrenal gland | 100% | 2917.72 | 258 / 258 | 96% | 9.95 | 220 / 230 |
kidney | 100% | 1838.03 | 89 / 89 | 95% | 11.12 | 855 / 901 |
ovary | 100% | 4501.34 | 180 / 180 | 94% | 9.74 | 403 / 430 |
liver | 100% | 1433.56 | 226 / 226 | 73% | 5.49 | 298 / 406 |
adipose | 100% | 3836.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3631.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 3951.03 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.66 | 1 / 1 |
muscle | 100% | 2378.18 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1795.55 | 843 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 14.07 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 90% | 13.03 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 83% | 7.39 | 66 / 80 |
peripheral blood | 73% | 1599.29 | 676 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_2000059 | Biological process | negative regulation of ubiquitin-dependent protein catabolic process |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0006361 | Biological process | transcription initiation at RNA polymerase I promoter |
GO_0034644 | Biological process | cellular response to UV |
GO_0051123 | Biological process | RNA polymerase II preinitiation complex assembly |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0006974 | Biological process | DNA damage response |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_1902806 | Biological process | regulation of cell cycle G1/S phase transition |
GO_1905524 | Biological process | negative regulation of protein autoubiquitination |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0071318 | Biological process | cellular response to ATP |
GO_0060261 | Biological process | positive regulation of transcription initiation by RNA polymerase II |
GO_0050821 | Biological process | protein stabilization |
GO_2000825 | Biological process | positive regulation of androgen receptor activity |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0042789 | Biological process | mRNA transcription by RNA polymerase II |
GO_0006367 | Biological process | transcription initiation at RNA polymerase II promoter |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0030901 | Biological process | midbrain development |
GO_0005730 | Cellular component | nucleolus |
GO_0071339 | Cellular component | MLL1 complex |
GO_0005669 | Cellular component | transcription factor TFIID complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005667 | Cellular component | transcription regulator complex |
GO_0005634 | Cellular component | nucleus |
GO_0001181 | Molecular function | RNA polymerase I general transcription initiation factor activity |
GO_0017025 | Molecular function | TBP-class protein binding |
GO_0016922 | Molecular function | nuclear receptor binding |
GO_0001091 | Molecular function | RNA polymerase II general transcription initiation factor binding |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1905502 | Molecular function | acetyl-CoA binding |
GO_0070577 | Molecular function | lysine-acetylated histone binding |
GO_0140416 | Molecular function | transcription regulator inhibitor activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0061628 | Molecular function | H3K27me3 modified histone binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0002039 | Molecular function | p53 binding |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0004402 | Molecular function | histone acetyltransferase activity |
GO_0016251 | Molecular function | RNA polymerase II general transcription initiation factor activity |
GO_0061631 | Molecular function | ubiquitin conjugating enzyme activity |
GO_0005515 | Molecular function | protein binding |
GO_0000979 | Molecular function | RNA polymerase II core promoter sequence-specific DNA binding |
Gene name | TAF1 |
Protein name | TATA-box binding protein associated factor 1 Alternative protein TAF1 Transcription initiation factor TFIID subunit Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250) |
Synonyms | BA2R TAF2A CCGS CCG1 |
Description | FUNCTION: The TFIID basal transcription factor complex plays a major role in the initiation of RNA polymerase II (Pol II)-dependent transcription . TFIID recognizes and binds promoters with or without a TATA box via its subunit TBP, a TATA-box-binding protein, and promotes assembly of the pre-initiation complex (PIC) . The TFIID complex consists of TBP and TBP-associated factors (TAFs), including TAF1, TAF2, TAF3, TAF4, TAF5, TAF6, TAF7, TAF8, TAF9, TAF10, TAF11, TAF12 and TAF13 . TAF1 is the largest component and core scaffold of the TFIID complex, involved in nucleating complex assembly . TAF1 forms a promoter DNA binding subcomplex of TFIID, together with TAF7 and TAF2 . Contains novel N- and C-terminal Ser/Thr kinase domains which can autophosphorylate or transphosphorylate other transcription factors . Phosphorylates TP53 on 'Thr-55' which leads to MDM2-mediated degradation of TP53 . Phosphorylates GTF2A1 and GTF2F1 on Ser residues . Possesses DNA-binding activity . Essential for progression of the G1 phase of the cell cycle . Exhibits histone acetyltransferase activity towards histones H3 and H4 . . |
Accessions | ENST00000461764.6 L8EAA9 A0A804HK00 ENST00000373775.8 ENST00000483985.3 ENST00000683715.1 A0A804HHS0 ENST00000683782.1 H0Y8N6 ENST00000683954.1 A0A804HIY8 ENST00000682124.1 A0A804HK58 H0Y9L7 H7BY98 A0AA75HR15 ENST00000683358.1 A0A804HJ48 ENST00000373790.9 [P21675-13] P21675 ENST00000485087.6 A0A804HJT5 ENST00000683668.1 ENST00000276072.9 A0A804HLH3 ENST00000423759.6 [P21675-14] ENST00000683202.1 ENST00000437147.8 ENST00000463163.5 ENST00000462588.5 A0A804HIC2 H7C2K9 ENST00000467309.5 A0A804HJ34 A0A804HJE0 |